Spermosens AB (XSAT:SPERM) OCF Margin %: 0.00% (As of Mar. 2026)


What is Spermosens AB OCF Margin %?

Spermosens AB XSAT:SPERM +1.96% OCF Margin % is 0.00% as of Mar. 2026. Among 204 Medical Diagnostics & Research companies, Spermosens AB ranks worse than 490195.59% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Spermosens AB's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-2.27 Mil. Spermosens AB's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Spermosens AB's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Spermosens AB's current OCF Yield % is -24.80%.

The historical rank and industry rank for Spermosens AB's OCF Margin % or its related term are showing as below:


During the past 7 years, the highest OCF Margin % of Spermosens AB was -14663.16%. The lowest was -34385.71%. And the median was -24524.44%.

XSAT:SPERM's OCF Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 4.755
* Ranked among companies with meaningful OCF Margin % only.

Spermosens AB OCF Margin % Related Terms

Spermosens AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for Spermosens AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Spermosens AB OCF Margin % Chart

Spermosens AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial -14,663.16 0.00 0.00 0.00 0.00

Spermosens AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Spermosens AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Spermosens AB's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-10.824/0
= %

Spermosens AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-2.266/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Spermosens AB (XSAT:SPERM) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spermosens AB and its competitors. According to the industry distribution chart, Spermosens AB ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry.
Is Spermosens AB's OCF Margin % too high?
Spermosens AB's current OCF Margin % is 0.00%. Based on the distribution chart, Spermosens AB ranks #999999 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Spermosens AB's OCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Spermosens AB ranks #999999 out of 204 companies for OCF Margin %. This places Spermosens AB in the lower half of its industry. The industry median OCF Margin % is 4.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Diagnostics & Research company?
The median OCF Margin % among Medical Diagnostics & Research companies is 4.76, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spermosens AB and its competitors. For the Medical Diagnostics & Research industry, the median OCF Margin % is 4.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spermosens AB's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spermosens AB stock overvalued right now?
Spermosens AB (XSAT:SPERM) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Spermosens AB (XSAT:SPERM), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Spermosens AB Business Description

Other Exchanges 9R5:Germany
Address Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Spermosens AB is developing a revolutionary platform technology for diagnosing male-factor infertility and directing to the right infertility treatment. It is a developer of medical device products for male infertility, individualizing In Vitro Fertilization (IVF) diagnostics and treatment creating a new standard for faster and safer IVF treatments.